68 / 68
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Tel
021 707 7000
Fax
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.zaCarzin XL.
Each film coated tablet contains 4 mg doxazosin. Reg. No.: RSA S3 41/7.1/0557. NAM NS2 10/34/0376. For full prescribing information, refer to the package insert approved by the Medicines Control Council, July 2009.
1)
Pompeo ACL,
et al.
A randomised, double blind study comparing the efficacy and tolerability of controlled release Doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia. Int J. Clin Pract Oct 2006;60(10):1172-
1177.
2)
Kirby RS,
et al.
A Combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. British
Journal of Urology International 2001 Feb;87(3):192-200.
3)
Carzin XL package insert.
4)
Vs. Doxazosin XL originator 4 mg modified release formulation. Department of Health website
. http://www.mpr.gov.za- Accessed 21/05/2015.
CLXC73/01/2015
DOXAZOSIN 4 mg
onset for
consistent flow
1
Slower
A
slower
onset of action vs IR formulations to allow
fewer titration steps and to minimize side-eects
2
.
Eective
treatment for urinary outflow obstruction
and BPH symptoms
3
.
Safe
BPH treatment for normotensive and
hypertensive patients
3
.
Carzin XL
, the extended release doxazosin oers:
SAVING
4
%
50
MORE THAN
A Lupin Group Company
Printed by Tandym Printers